Skip to main content
TipRanks
Go Ultimate75% OFF

Renalytix (RENX) Stock Statistics & Valuation Metrics

22 Followers

Total Valuation

Renalytix has a market cap or net worth of GBX 36.20M. The enterprise value is GBX 13.29M.

Market Cap
GBX 36.20M
Enterprise Value
GBX 13.29M

Share Statistics

Renalytix has 670,459,350 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
670,459,350
Owned by Insiders
3.73%
Owned by Institutions
0.02%

Financial Efficiency

Renalytix’s return on equity (ROE) is 2.25 and return on invested capital (ROIC) is 2247.91%.

Return on Equity (ROE)
2.25
Return on Assets (ROA)
-3.08
Return on Invested Capital (ROIC)
2247.91%
Return on Capital Employed (ROCE)
17.45
Revenue Per Employee
65.38K
Profits Per Employee
-309.47K
Employee Count
46
Asset Turnover
0.65
Inventory Turnover
3.79

Valuation Ratios

The current PE Ratio of Renalytix is -3.37. Renalytix’s PEG ratio is -0.04.

PE Ratio
-3.37
PS Ratio
29.90
PB Ratio
-22.74
Price to FCF
-8.70
Price to Operating Cash Flow
-5.05
PEG Ratio
-0.04

Income Statement

In the last 12 months, Renalytix had revenue of 3.01M and earned -14.24M in profits. Earnings per share was -0.03.

Revenue
3.01M
Gross Profit
1.10M
Operating Income
-14.03M
Pretax Income
-14.74M
Net Income
-14.24M
EBITDA
-13.83M
Earnings Per Share (EPS)
-0.03

Cash Flow

In the last 12 months, operating cash flow was -5.40M and capital expenditures -100,000, giving a free cash flow of -5.50M billion.

Operating Cash Flow
-5.40M
Free Cash Flow
-5.50M
Free Cash Flow per Share
-0.01

Dividends & Yields

Renalytix pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-11.50%
Earnings Yield
-29.68%

Stock Price Statistics

Beta
-0.54
52-Week Price Change
-21.17%
50-Day Moving Average
5.68
200-Day Moving Average
3.45
Relative Strength Index (RSI)
43.63
Average Volume (3m)
1.41M

Important Dates

Renalytix upcoming earnings date is Dec 08, 2026, TBA (Not Confirmed).

Last Earnings Date
Oct 28, 2026
Next Earnings Date
Dec 08, 2026
Ex-Dividend Date
―

Financial Position

Renalytix as a current ratio of 0.61, with Debt / Equity ratio of -90.48%

Current Ratio
0.61
Quick Ratio
0.52
Debt to Market Cap
0.39
Net Debt to EBITDA
-0.31
Interest Coverage Ratio
-23.33

Taxes

In the past 12 months, Renalytix has paid -501.25K in taxes.

Income Tax
-501.25K
Effective Tax Rate
0.03

Enterprise Valuation

Renalytix EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -8.64.

EV to Sales
29.71
EV to EBITDA
0.00
EV to Free Cash Flow
-8.64
EV to Operating Cash Flow
-8.80

Balance Sheet

Renalytix has GBX 6.20M in cash and marketable securities with GBX 5.80M in debt, giving a net cash position of GBX 400.00K billion.

Cash & Marketable Securities
GBX 6.20M
Total Debt
GBX 5.80M
Net Cash
GBX 400.00K
Net Cash Per Share
GBX 0.00
Tangible Book Value Per Share
GBX 0.00

Margins

Gross margin is 50.00%, with operating margin of -443.75%, and net profit margin of -506.25%.

Gross Margin
50.00%
Operating Margin
-443.75%
Pretax Margin
-506.25%
Net Profit Margin
-506.25%
EBITDA Margin
0.00%
EBIT Margin
-437.50%

Scores

Smart Score
―
AI Score
45